Historical Market Performance : China Natural Gas

The following tables show the Debt/Equity Ratios before and after both exchanges based on book value of debt. As it is observed, the transactions did not significantly alter the

The income over the last three years has been fluctuating.. This tells us the company has an initial growth period. Sales also drop between years 7 and 8 and the gross profit margin decreased as well. This may be due to operating expenses. This leads to the prospect of stable future sales. The stakeholders are continuing to back the company and the company does predict sales will remain stable. The modest increase in sales does not show enough to recover without making adjustments to free capital.

From the industry benchmark report for 2014, (appendix) between the year 2013 and 2014 our share value increased from 15.80 to 27.04 placing us ahead of everyone in our world. That is an increase of 172%. From out firm reports (appendix), our net income of 2,764,446 unfortunately fell short of our profit forecast. of 3,501,014. Even though our share holder’s value was the highest amongst our competitors, our profit before taxes was second to Bikes ‘R’Us by a total of $450,000. They had a profit of 4,339,987 while we only had a profit of 3,949,209. A part of the reason why our net income didn’t meet our forecasts and profit before taxes fell short of Bikes’R’Us is due to

The firm shows positive health for the Shareholders Equity with an equity ratio of 44.2% in 2011 and increasing to 45.2% in 2012. Calculating the percent of total assets that shareholders would receive in the event of company liquidation looks positive and very healthy for any investors or shareholders of this firm. The interest coverage ratio is also at a value that is significantly positive 14.0% in 2011 and 12.8% in 2012. Although 2021 shows a decrease, the company is still very capable of generating sufficient revenues to cover their interest payments on any debt they have incurred.

By using the consolidated income statements, balance sheet and cash flow statement, we can assess the company’s financial position. On the income statement, the company’s operation revenue increased by 4.5% ($393.4 million) from year 2006 while its operating income decreased by $65.1 million in the same period. Without considering the net-cash settlement feature expense recorded in 2007, operating income increased $103.6 million. Even though including the net-cash settlement feature

After that, we analyses the company’s financial performance through analyses the recent three years’ annual report from 2013 to 2015. Based the previous steps, we could conduct the evaluation of the company through many comprehensive indexes like WACC and two-stage discounted free cash flow model, we get the stock price by both FCFF and FCFE are $8.06 and $7.44 respectively , compare to the current price of 20 May 2016 is $10.36, and the price is overvalued.

The return on equity (ROE) has also shown an increase in 2009 over the previous year suggesting a successful investment by shareholders. This increase, coupled with the fact that the basic earnings per share (EPS) has increased significantly from 61.78 cents in 2008 to 88.26 cents in 2009 (143%) shows great improvement in the profit per share. Please note that the basic EPS has been used in this analysis as the diluted EPS includes employee options (JBH Annual Report, 2009), skewing and reducing the value of the EPS.

1. Blake, Hannah. “A history of Merck & Co”. Pharmaphorum. May 30, 2013. Retrieved from http://www.pharmaphorum.com/articles/a-history-of-merck-co

Economic benefits of the natural gas industry are intimately tied to the market price of natural gas – which historically, has demonstrated high volatility. Recently the price for oil and gas has plummeted. While natural gas supplies steadily accumulated in the US, Canada’s main export market, decreasing revenue and profits. This has resulted in consolidation of oil and gas companies, loss in jobs, and delay/cancelling of new projects (e.g., LNG projects on BC’s coast). Given this financial context, the Canadian gas industry needs to streamline their operations (i.e., increase efficiency and productivity) and explore alternative markets by, perhaps, moving methane up the value chain and creating value-added products (i.e., petrochemicals).

With the net result is being an overstated net income, during the company’s record profit and double digit growth years, creating a high dividend for investors.

Total shareholders’ equity increased $21,735,000 or 3.9% YoY. Capital stock and contributed surplus increases were quite insignificant, but accumulated other comprehensive income increased 114.4% YoY, and the accumulated deficit decreased $77,104,000 or 54.2% YoY. Other equity is now at zero from ($154,239,000) last year (refer to financial liability) due to the final payment made for the remaining 45% stake in Honsel

However, at the ex-dividend date, May 12, 1989, the price of stock turned out to be about $13.5/share (from Historical Stock Price Performance of Sealed Air Corporation New York Stock Exchange Ticket SEE), which means the value of equity increased after the recapitalization. This part is the value generated in the leveraged recapitalization.

On April 1, 2011, the SEC suspended trading in CHJI because questions had arisen regarding the accuracy and completeness of information contained in CHJI’s public filings concerning, among other things, the company’s financial statements for 2009 and 2010. CHJI also failed to disclose that it filed its most recent Form 10-Q without the

This price is edging near the company’s fifty-two week high of 178.91 dollars per share, and is the highest stock price in the 3 month period. This stock’s fifty-two week low was recorded at 122.03 dollars per share. This is over thirty dollars less than the lowest stock price in the 3 month period, 155.52 dollars per share, experienced on November 1, 2016. Our team had originally purchased shares forty of the stock for 164. 78 dollars per share. An additional 40 shares of Bio-Rad were purchased for 162.57 dollars per share. In total our team made $383.49 ( 6.26% in realized gains) off of Bio-Rad stock. Our team should have delayed selling the stock until November 15, instead of selling on November 9, when the price was at the top of the bollinger bands. Overall, Bio-Rad was a high performing stock, however, investors should conduct technical and qualitative analysis before purchasing any shares of this company. Likewise, investors should listen for new product lines Bio-Rad puts out; these products increase the value of the

Our choices led to a constant increase in net income over the three years. Short term debt increase by approximately 100% percent but steadily reduced over the next three years. We were happy with the positive growth of the company and the fact that we were able to pay off most of the initial short term funding required by the increase in working capital requirement. Overall the current situation of the company in 2018 is good, although the total value created is less than 20% of that created in phase 1. From this we learned that the value of the firm can be significantly increased more through a reduction in working capital requirement than through increasing the firm’s sales and net income.